1. Home
  2. NTRA vs HPQ Comparison

NTRA vs HPQ Comparison

Compare NTRA & HPQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • HPQ
  • Stock Information
  • Founded
  • NTRA 2003
  • HPQ 1939
  • Country
  • NTRA United States
  • HPQ United States
  • Employees
  • NTRA N/A
  • HPQ N/A
  • Industry
  • NTRA Medical Specialities
  • HPQ Computer Manufacturing
  • Sector
  • NTRA Health Care
  • HPQ Technology
  • Exchange
  • NTRA Nasdaq
  • HPQ Nasdaq
  • Market Cap
  • NTRA 21.7B
  • HPQ 23.5B
  • IPO Year
  • NTRA 2015
  • HPQ N/A
  • Fundamental
  • Price
  • NTRA $163.02
  • HPQ $26.74
  • Analyst Decision
  • NTRA Strong Buy
  • HPQ Hold
  • Analyst Count
  • NTRA 16
  • HPQ 12
  • Target Price
  • NTRA $193.50
  • HPQ $30.46
  • AVG Volume (30 Days)
  • NTRA 1.7M
  • HPQ 7.4M
  • Earning Date
  • NTRA 08-07-2025
  • HPQ 08-27-2025
  • Dividend Yield
  • NTRA N/A
  • HPQ 4.33%
  • EPS Growth
  • NTRA N/A
  • HPQ N/A
  • EPS
  • NTRA N/A
  • HPQ 2.61
  • Revenue
  • NTRA $1,964,250,000.00
  • HPQ $54,298,000,000.00
  • Revenue This Year
  • NTRA $19.98
  • HPQ $3.19
  • Revenue Next Year
  • NTRA $16.16
  • HPQ $1.53
  • P/E Ratio
  • NTRA N/A
  • HPQ $10.25
  • Revenue Growth
  • NTRA 44.38
  • HPQ 2.45
  • 52 Week Low
  • NTRA $110.57
  • HPQ $21.21
  • 52 Week High
  • NTRA $183.00
  • HPQ $39.80
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 65.28
  • HPQ 60.54
  • Support Level
  • NTRA $152.62
  • HPQ $24.79
  • Resistance Level
  • NTRA $161.92
  • HPQ $27.33
  • Average True Range (ATR)
  • NTRA 6.11
  • HPQ 0.63
  • MACD
  • NTRA 3.42
  • HPQ 0.20
  • Stochastic Oscillator
  • NTRA 93.78
  • HPQ 81.68

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About HPQ HP Inc.

HP (formerly Hewlett-Packard) is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.

Share on Social Networks: